Please assess the completion status of the following clinical trial:

Trial Title: ORIC-I: Optimizing Recovery From Intensive Care: Mechanical Ventilation and Delirium

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* All adult (\>=18 years of age) mechanically ventilated patients admitted to the medical, surgical, trauma, or cardiothoracic ICUs of the UPMC main campus who are expected by the ICU clinical team to require \>24 hours of mechanical ventilation~Exclusion Criteria:~* Baseline QTc \>480 milliseconds (ms); history of Parkinson's disease; pregnancy; history of schizophrenia or neurologic disease that would confound the delirium assessment; deafness or inability to understand English or Spanish; extubation prior to enrollment; previously enrolled in this study; patient, family, or attending physician refusal; death before enrollment; treatment with haloperidol within 2 days prior to ICU admission; and prisoners.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- haloperidol (Type: EXPERIMENTAL): Once diagnosed as delirious, randomized to haloperidol 5 mg IV
- placebo (Type: PLACEBO_COMPARATOR): once diagnosed as delirious, received 5 mg saline placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).